Skip to content

NAVIDEA BIOPHARMACEUTICALS, INC.: 10-Q filed 2018-08-08

What NAVIDEA BIOPHARMACEUTICALS, INC. reported in its quarterly report filed 2018-08-08 (fiscal Q2 2018): 45 published measures, 122 facts as tagged in accession 0001437749-18-014956.

This filing

Form
10-Q (quarterly report)
Filed
2018-08-08
Fiscal period
fiscal Q2 2018
Accession
0001437749-18-014956 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All NAVIDEA BIOPHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-06-308,660,492USD
At 2017-12-3120,781,436USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-06-305,873,620USD
At 2017-12-318,733,106USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-06-302,118,197USD
At 2017-12-3111,379,630USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-06-304,690,973USD
At 2017-12-312,795,006USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-06-308,289,794USD181
2017-01-01 to 2017-06-3061,992,252USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-04-01 to 2018-06-303,165USD91
2018-01-01 to 2018-06-303,165USD181
2017-04-01 to 2017-06-308,170USD91
2017-01-01 to 2017-06-308,170USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-04-01 to 2018-06-30542,127USD91
2018-01-01 to 2018-06-30818,572USD181
2017-04-01 to 2017-06-30611,599USD91
2017-01-01 to 2017-06-301,191,629USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-01-01 to 2018-06-30-7,390,662USD181
2017-01-01 to 2017-06-30-60,890,558USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-06-30996,835USD181
2017-01-01 to 2017-06-30-2,008,170USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-06-30-329,740,962USD
At 2018-01-01-320,608,968USD
At 2017-12-31-319,908,968USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2018-04-01 to 2018-06-30162,716,988shares91
2018-01-01 to 2018-06-30162,494,238shares181
2017-04-01 to 2017-06-30161,910,792shares91
2017-01-01 to 2017-06-30161,147,873shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2018-04-01 to 2018-06-30162,716,988shares91
2018-01-01 to 2018-06-30162,494,238shares181
2017-04-01 to 2017-06-30161,910,792shares91
2017-01-01 to 2017-06-30165,631,000shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-0.02USD/shares91
2018-01-01 to 2018-06-30-0.06USD/shares181
2017-04-01 to 2017-06-30-0.03USD/shares91
2017-01-01 to 2017-06-300.5USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-0.02USD/shares91
2018-01-01 to 2018-06-30-0.06USD/shares181
2017-04-01 to 2017-06-30-0.03USD/shares91
2017-01-01 to 2017-06-300.49USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-10,929USD91
2018-01-01 to 2018-06-30-10,929USD181
2017-04-01 to 2017-06-30-1,631,234USD91
2017-01-01 to 2017-06-30-3,085,406USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-06-30179,200USD
At 2017-12-31236,701USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-01-01 to 2018-06-30217,147USD181
2017-01-01 to 2017-06-30256,384USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-2,425,382USD91
2018-01-01 to 2018-06-30-4,924,583USD181
2017-04-01 to 2017-06-30-4,823,859USD91
2017-01-01 to 2017-06-30-7,971,537USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-06-306,600,121USD
At 2017-12-3113,832,405USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-06-304,628,943USD
At 2017-12-318,068,403USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-06-30453,720USD
At 2017-12-31855,043USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2018-06-30443,324USD
At 2017-12-31458,156USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-04-01 to 2018-06-302,932,117USD91
2018-01-01 to 2018-06-305,707,445USD181
2017-04-01 to 2017-06-305,435,458USD91
2017-01-01 to 2017-06-309,163,166USD181

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2018-04-01 to 2018-06-30506,735USD91
2018-01-01 to 2018-06-30782,862USD181
2017-04-01 to 2017-06-30611,599USD91
2017-01-01 to 2017-06-301,191,629USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2018-04-01 to 2018-06-3035,392USD91
2018-01-01 to 2018-06-3035,710USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2018-04-01 to 2018-06-301,789,399USD91
2018-01-01 to 2018-06-303,565,771USD181
2017-04-01 to 2017-06-304,249,584USD91
2017-01-01 to 2017-06-307,272,018USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-04-01 to 2018-06-301,142,718USD91
2018-01-01 to 2018-06-302,141,674USD181
2017-04-01 to 2017-06-301,185,874USD91
2017-01-01 to 2017-06-301,891,148USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-06-30163,620,090shares
At 2017-12-31162,206,646shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-06-30331,697,603USD
At 2017-12-31331,128,787USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2018-06-302,786,872USD
At 2017-12-3112,048,330USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-06-301,208,158USD
At 2017-12-311,206,058USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-06-301,028,958USD
At 2017-12-31969,357USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2018-06-301,437,847USD
At 2017-12-311,444,798USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2018-06-3065,111USD
At 2017-12-3165,587USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2018-06-30737,336USD
At 2017-12-311,101,923USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-2,446,101USD91
2018-01-01 to 2018-06-30-9,184,063USD181
2017-04-01 to 2017-06-30-4,783,011USD91
2017-01-01 to 2017-06-30-9,101,798USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-2,394,057USD91
2018-01-01 to 2018-06-30-9,132,019USD181
2017-04-01 to 2017-06-30-5,187,531USD91
2017-01-01 to 2017-06-3080,393,494USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-2,394,041USD91
2018-01-01 to 2018-06-30-9,131,994USD181
2017-04-01 to 2017-06-30-5,187,564USD91
2017-01-01 to 2017-06-3080,393,663USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2018-01-01 to 2018-06-3075,498USD181
2017-01-01 to 2017-06-30161,751USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2018-04-01 to 2018-06-302,828USD91
2018-01-01 to 2018-06-30-1,886USD181
2017-04-01 to 2017-06-30-16,673USD91
2017-01-01 to 2017-06-30-38,277USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2018-01-01 to 2018-06-304,000USD181
2017-01-01 to 2017-06-307,400,000USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2018-01-01 to 2018-06-30200USD181
2017-01-01 to 2017-06-3054,319USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-06-30-12,573,372USD181
2017-01-01 to 2017-06-3014,642,466USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-06-30-1,470,826USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-06-30-401,323USD181
2017-01-01 to 2017-06-30-5,502,541USD181

Inspect the source

Entity
NAVIDEA BIOPHARMACEUTICALS, INC. / CIK 0000810509
Captured
SEC response SHA-256
e6e15b291454205779be87d7d17e86894a378fd299b7dd1312591814ed2d7c83

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000810509.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))